Self-expanding TAVR as good as surgery in intermediate-risk patients

(American College of Cardiology) Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart surgery in intermediate risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news